Atlas Trials

A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors and Colorectal, and Breast Cancers

Clinical trial NCT03251378 · COMPLETED

Trial details

NCT number
NCT03251378
Sponsor
Hutchison Medipharma Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid TumorsMetastatic Colon CancerMetastatic Breast CancerTriple Negative Breast CancerHER2-negative Breast CancerHormone Receptor Positive Breast CarcinomaRectal Cancer
Start date
2017-12-11
Primary completion
2022-12-13
Enrollment
129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.